Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001193125-25-285071
Filing Date
2025-11-17
Accepted
2025-11-17 21:45:06
Documents
2
Period of Report
2025-11-10

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1512
2 EX-24 ck0001800315-ex24.htm EX-24 10746
  Complete submission text file 0001193125-25-285071.txt   13769
Mailing Address 75 STATE STREET SUITE 100 BOSTON MA 02109
Business Address 75 STATE STREET SUITE 100 BOSTON MA 02109 45-70-70-52-10
Galecto, Inc. (Issuer) CIK: 0001800315 (see all company filings)

EIN.: 371957007 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 2001 MARKET STREET SUITE 2500 PHILADELPHIA PA 19103
Business Address
CAIN CHRISTOPHER W. (Reporting) CIK: 0001817733 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39655 | Film No.: 251492636